257 related articles for article (PubMed ID: 7288650)
1. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
Leysen JE
J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
[TBL] [Abstract][Full Text] [Related]
2. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
Nelson DL; Pedigo NW; Yamamura HI
J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652
[TBL] [Abstract][Full Text] [Related]
3. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
4. Multiple serotonin receptors and their physiological significance.
Peroutka SJ; Snyder SH
Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
[TBL] [Abstract][Full Text] [Related]
5. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
Peroutka SJ; Snyder SH
Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
[No Abstract] [Full Text] [Related]
6. Characterization of solubilized serotonin (S2) receptors in rat brain.
Ilien B; Gorissen H; Laduron PM
Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
[TBL] [Abstract][Full Text] [Related]
7. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
Peroutka SJ; Snyder SH
Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
[TBL] [Abstract][Full Text] [Related]
8. Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies.
Ebersole BJ; Weinstein H; Maayani S
J Pharmacol Exp Ther; 1984 Jun; 229(3):865-71. PubMed ID: 6726661
[TBL] [Abstract][Full Text] [Related]
9. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
Burris KD; Sanders-Bush E
Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
[TBL] [Abstract][Full Text] [Related]
10. The distribution of serotonergic 5-HT1A and non-5-HT1A recognition sites along the dorso-ventral axis of the rat hippocampus.
Kiedrowski L
Pol J Pharmacol Pharm; 1991; 43(2):103-13. PubMed ID: 1946036
[TBL] [Abstract][Full Text] [Related]
11. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
Pranzatelli MR; Gregory CM
Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
[TBL] [Abstract][Full Text] [Related]
12. Serotonin receptors in hippocampus and frontal cortex.
Seeman P; Westman K; Coscina D; Warsh JJ
Eur J Pharmacol; 1980 Aug; 66(2-3):179-91. PubMed ID: 7439270
[TBL] [Abstract][Full Text] [Related]
13. [3H]tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites.
Perry DC
J Pharmacol Exp Ther; 1986 Feb; 236(2):548-59. PubMed ID: 3003349
[TBL] [Abstract][Full Text] [Related]
14. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
[TBL] [Abstract][Full Text] [Related]
15. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
Oelszner W
Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
[TBL] [Abstract][Full Text] [Related]
16. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex.
Wagner HR; Reches A; Yablonskaya E; Fahn S
Adv Neurol; 1986; 43():645-51. PubMed ID: 2418653
[TBL] [Abstract][Full Text] [Related]
17. Interactions of [3H]LSD with serotonin receptors in human brain.
Cross AJ
Eur J Pharmacol; 1982 Aug; 82(1-2):77-80. PubMed ID: 7128680
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydro-beta-carbolines: affinities for tryptamine and serotonergic binding sites.
Cascio CS; Kellar KJ
Neuropharmacology; 1982 Nov; 21(11):1219-21. PubMed ID: 7177348
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
